Literature DB >> 34324787

Calcium signaling induces a partial EMT.

Robert J Norgard1, Jason R Pitarresi1, Ravikanth Maddipati2, Nicole M Aiello-Couzo1, David Balli1, Jinyang Li1, Taiji Yamazoe1, Maximilian D Wengyn1, Ian D Millstein1, Ian W Folkert1,3, Derick N Rosario-Berrios4, Il-Kyu Kim1, Jared B Bassett1, Riley Payne5, Corbett T Berry6, Xiaodong Feng7,8, Kathryn Sun1, Michele Cioffi9, Priyanka Chakraborty10, Mohit Kumar Jolly10, J Silvio Gutkind7, David Lyden9, Bruce D Freedman6, J Kevin Foskett5,11, Anil K Rustgi12, Ben Z Stanger1,11.   

Abstract

Epithelial plasticity, or epithelial-to-mesenchymal transition (EMT), is a well-recognized form of cellular plasticity, which endows tumor cells with invasive properties and alters their sensitivity to various agents, thus representing a major challenge to cancer therapy. It is increasingly accepted that carcinoma cells exist along a continuum of hybrid epithelial-mesenchymal (E-M) states and that cells exhibiting such partial EMT (P-EMT) states have greater metastatic competence than those characterized by either extreme (E or M). We described recently a P-EMT program operating in vivo by which carcinoma cells lose their epithelial state through post-translational programs. Here, we investigate the underlying mechanisms and report that prolonged calcium signaling induces a P-EMT characterized by the internalization of membrane-associated E-cadherin (ECAD) and other epithelial proteins as well as an increase in cellular migration and invasion. Signaling through Gαq-associated G-protein-coupled receptors (GPCRs) recapitulates these effects, which operate through the downstream activation of calmodulin-Camk2b signaling. These results implicate calcium signaling as a trigger for the acquisition of hybrid/partial epithelial-mesenchymal states in carcinoma cells.
© 2021 The Authors.

Entities:  

Keywords:  E-cadherin; calcium; cellular plasticity; partial EMT

Mesh:

Substances:

Year:  2021        PMID: 34324787      PMCID: PMC8419705          DOI: 10.15252/embr.202051872

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   9.071


  41 in total

Review 1.  NFAT signaling: choreographing the social lives of cells.

Authors:  Gerald R Crabtree; Eric N Olson
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

Review 2.  EMT: 2016.

Authors:  M Angela Nieto; Ruby Yun-Ju Huang; Rebecca A Jackson; Jean Paul Thiery
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

Review 3.  The calcium-cancer signalling nexus.

Authors:  Gregory R Monteith; Natalia Prevarskaya; Sarah J Roberts-Thomson
Journal:  Nat Rev Cancer       Date:  2017-04-07       Impact factor: 60.716

Review 4.  NFAT proteins: emerging roles in cancer progression.

Authors:  Maria Mancini; Alex Toker
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

Review 5.  Parathyroid Hormone-Related Protein, Its Regulation of Cartilage and Bone Development, and Role in Treating Bone Diseases.

Authors:  T John Martin
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

6.  Global Regulation of the Histone Mark H3K36me2 Underlies Epithelial Plasticity and Metastatic Progression.

Authors:  Salina Yuan; Ramakrishnan Natesan; Francisco J Sanchez-Rivera; Jinyang Li; Natarajan V Bhanu; Taiji Yamazoe; Jeffrey H Lin; Allyson J Merrell; Yogev Sela; Stacy K Thomas; Yanqing Jiang; Jacqueline B Plesset; Emma M Miller; Junwei Shi; Benjamin A Garcia; Scott W Lowe; Irfan A Asangani; Ben Z Stanger
Journal:  Cancer Discov       Date:  2020-03-18       Impact factor: 39.397

Review 7.  Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.

Authors:  Mohit Kumar Jolly; Jason A Somarelli; Maya Sheth; Adrian Biddle; Satyendra C Tripathi; Andrew J Armstrong; Samir M Hanash; Sharmila A Bapat; Annapoorni Rangarajan; Herbert Levine
Journal:  Pharmacol Ther       Date:  2018-09-28       Impact factor: 12.310

8.  Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy.

Authors:  Jinyang Li; Katelyn T Byrne; Fangxue Yan; Taiji Yamazoe; Zeyu Chen; Timour Baslan; Lee P Richman; Jeffrey H Lin; Yu H Sun; Andrew J Rech; David Balli; Ceire A Hay; Yogev Sela; Allyson J Merrell; Shannon M Liudahl; Naomi Gordon; Robert J Norgard; Salina Yuan; Sixiang Yu; Timothy Chao; Shuai Ye; T S Karin Eisinger-Mathason; Robert B Faryabi; John W Tobias; Scott W Lowe; Lisa M Coussens; E John Wherry; Robert H Vonderheide; Ben Z Stanger
Journal:  Immunity       Date:  2018-06-26       Impact factor: 43.474

9.  Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.

Authors:  Cornelia Kröger; Alexander Afeyan; Jasmin Mraz; Elinor Ng Eaton; Ferenc Reinhardt; Yevgenia L Khodor; Prathapan Thiru; Brian Bierie; Xin Ye; Christopher B Burge; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-25       Impact factor: 11.205

10.  Tumour exosome integrins determine organotropic metastasis.

Authors:  Ayuko Hoshino; Bruno Costa-Silva; Tang-Long Shen; Goncalo Rodrigues; Ayako Hashimoto; Milica Tesic Mark; Henrik Molina; Shinji Kohsaka; Angela Di Giannatale; Sophia Ceder; Swarnima Singh; Caitlin Williams; Nadine Soplop; Kunihiro Uryu; Lindsay Pharmer; Tari King; Linda Bojmar; Alexander E Davies; Yonathan Ararso; Tuo Zhang; Haiying Zhang; Jonathan Hernandez; Joshua M Weiss; Vanessa D Dumont-Cole; Kimberly Kramer; Leonard H Wexler; Aru Narendran; Gary K Schwartz; John H Healey; Per Sandstrom; Knut Jørgen Labori; Elin H Kure; Paul M Grandgenett; Michael A Hollingsworth; Maria de Sousa; Sukhwinder Kaur; Maneesh Jain; Kavita Mallya; Surinder K Batra; William R Jarnagin; Mary S Brady; Oystein Fodstad; Volkmar Muller; Klaus Pantel; Andy J Minn; Mina J Bissell; Benjamin A Garcia; Yibin Kang; Vinagolu K Rajasekhar; Cyrus M Ghajar; Irina Matei; Hector Peinado; Jacqueline Bromberg; David Lyden
Journal:  Nature       Date:  2015-10-28       Impact factor: 49.962

View more
  7 in total

1.  Meaningful connections: Interrogating the role of physical fibroblast cell-cell communication in cancer.

Authors:  Jaye C Gardiner; Edna Cukierman
Journal:  Adv Cancer Res       Date:  2022-02-24       Impact factor: 5.767

2.  The role of calcium oscillations in the phenotype selection in endothelial cells.

Authors:  Birses Debir; Cameron Meaney; Mohammad Kohandel; M Burcin Unlu
Journal:  Sci Rep       Date:  2021-12-10       Impact factor: 4.379

3.  Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis.

Authors:  Maalavika Pillai; Gouri Rajaram; Pradipti Thakur; Nilay Agarwal; Srinath Muralidharan; Ankita Ray; Dev Barbhaya; Jason A Somarelli; Mohit Kumar Jolly
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

Review 4.  Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.

Authors:  Goodwin G Jinesh; Andrew S Brohl
Journal:  Signal Transduct Target Ther       Date:  2022-08-23

Review 5.  Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis.

Authors:  Xutengyue Tian; Jiayi Wang; Lanxin Jiang; Yuchen Jiang; Juan Xu; Xiaodong Feng
Journal:  J Oncol       Date:  2022-10-11       Impact factor: 4.501

6.  P4HA2: A link between tumor-intrinsic hypoxia, partial EMT and collective migration.

Authors:  Vaishali Aggarwal; Sarthak Sahoo; Vera S Donnenberg; Priyanka Chakraborty; Mohit Kumar Jolly; Shilpa Sant
Journal:  Adv Cancer Biol Metastasis       Date:  2022-07-31

7.  Calcium signaling induces a partial EMT.

Authors:  Robert J Norgard; Jason R Pitarresi; Ravikanth Maddipati; Nicole M Aiello-Couzo; David Balli; Jinyang Li; Taiji Yamazoe; Maximilian D Wengyn; Ian D Millstein; Ian W Folkert; Derick N Rosario-Berrios; Il-Kyu Kim; Jared B Bassett; Riley Payne; Corbett T Berry; Xiaodong Feng; Kathryn Sun; Michele Cioffi; Priyanka Chakraborty; Mohit Kumar Jolly; J Silvio Gutkind; David Lyden; Bruce D Freedman; J Kevin Foskett; Anil K Rustgi; Ben Z Stanger
Journal:  EMBO Rep       Date:  2021-07-29       Impact factor: 9.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.